Gregory M. Richards, MD Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Dr. Gregory Richards earned his medical degree from New Jersey Medical School and completed his residency at University of Wisconsin Hospital and Clinics.
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
UW School of Medicine and Public Health
|Department of Human Oncology|
Professional Certifications and Education
University of Wisconsin Hospital and Clinics, Madison, WI
St. Vincent's Hospital, New York, NY
College of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, NJ, 2001
Adkison JB Tomé W Seo S Richards GM Robins HI Rassmussen K Welsh JS Mahler PA Howard SP .
Reirradiation of large-volume recurrent glioma with pulsed reduced-dose-rate radiotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):835-41
[PubMed ID: 20472350]
Traynor AM Richards GM Hartig GK Khuntia D Cleary JF Wiederholt PA Bentzen SM Harari PM .
Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience. Head Neck. 2010 May;32(5):599-606
[PubMed ID: 19757422]
Francis D Richards GM Forouzannia A Mehta MP Khuntia D .
Motexafin gadolinium: a novel radiosensitizer for brain tumors. Expert Opin Pharmacother. 2009 Sep;10(13):2171-80
[PubMed ID: 19640206]
Richards GM Tomé WA Robins HI Stewart JA Welsh JS Mahler PA Howard SP .
Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region. Breast Cancer Res Treat. 2009 Mar;114(2):307-13
[PubMed ID: 18389365]
Hodge CW Bentzen SM Wong G Palazzi-Churas KL Wiederholt PA Gondi V Richards GM Hartig GK Harari PM .
Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparison. Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1032-41
[PubMed ID: 17967300]
Forouzannia A Richards GM Khuntia D Mehta MP .
Motexafin gadolinium: a novel radiosensitizer for brain tumors. Expert Rev Anticancer Ther. 2007 Jun;7(6):785-94
[PubMed ID: 17555388]
Richards GM Mehta MP .
Motexafin gadolinium in the treatment of brain metastases. Expert Opin Pharmacother. 2007 Feb;8(3):351-9
[PubMed ID: 17266469]
Richards GM Khuntia D Mehta MP .
Therapeutic management of metastatic brain tumors. Crit Rev Oncol Hematol. 2007 Jan;61(1):70-8
[PubMed ID: 16949297]
Sewall GK Palazzi-Churas KL Richards GM Hartig GK Harari PM .
Planned postradiotherapy neck dissection: Rationale and clinical outcomes. Laryngoscope. 2007 Jan;117(1):121-8
[PubMed ID: 17202940]
Soisson ET Tomé WA Richards GM Mehta MP .
Comparison of linac based fractionated stereotactic radiotherapy and tomotherapy treatment plans for skull-base tumors. Radiother Oncol. 2006 Mar;78(3):313-21
[PubMed ID: 16490269]
Richards GM Bradley KA Tomé WA Bentzen SM Resnick DK Mehta MP .
Linear accelerator radiosurgery for trigeminal neuralgia. Neurosurgery. 2005 Dec;57(6):1193-200; discussion 1193-200
[PubMed ID: 16331167]